Profile
Sector:
HealthcareCountry:
United StatesIPO:
20 September 2018Website:
http://www.elanco.comNext earnings report:
07 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 6 min agoDividend
Analysts recommendations
Institutional Ownership
ELAN Latest News
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) of a class action securities lawsuit.
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=110612&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 7, 2023 and June 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 6, 2024.
PHILADELPHIA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Elanco Animal Health (“Elanco” or the “Company”) (NYSE: ELAN) on behalf of purchasers of ELANCO securities between November 7, 2023 and June 26, 2024, inclusive (the “Class Period”) .
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=110546&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated.
NEW YORK , Nov. 4, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Elanco Animal Health Incorporated (NYSE: ELAN). Shareholders who purchased shares of ELAN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=110497&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, Nov. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elanco Animal Health Incorporated (NYSE: ELAN) between November 7, 2023 and June 26, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead plaintiff deadline.
NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=110477&wire=1 or contact Joseph E. Levi, Esq.
What type of business is Elanco Animal Health Incorporated?
Elanco Animal Health Incorporated is a pharmaceutical company that develops and markets products for the treatment of animals. The Prevention of diseases in domestic animals segment includes a wide range of parasiticides. The Therapy for domestic animals segment provides means and services for pain and osteoarthritis treatment, with different modes of action, indications, and disease stages. The Protein and Health segment includes vaccines, food enzymes, and antibiotics for animals. The Ruminant and Swine category segment is engaged in the development of vaccines, antibiotics, implants, parasiticides, and animal origin products widely used in the breeding of ruminant animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
What sector is Elanco Animal Health Incorporated in?
Elanco Animal Health Incorporated is in the Healthcare sector
What industry is Elanco Animal Health Incorporated in?
Elanco Animal Health Incorporated is in the Drug Manufacturers - Specialty & Generic industry
What country is Elanco Animal Health Incorporated from?
Elanco Animal Health Incorporated is headquartered in United States
When did Elanco Animal Health Incorporated go public?
Elanco Animal Health Incorporated initial public offering (IPO) was on 20 September 2018
What is Elanco Animal Health Incorporated website?
https://www.elanco.com
Is Elanco Animal Health Incorporated in the S&P 500?
No, Elanco Animal Health Incorporated is not included in the S&P 500 index
Is Elanco Animal Health Incorporated in the NASDAQ 100?
No, Elanco Animal Health Incorporated is not included in the NASDAQ 100 index
Is Elanco Animal Health Incorporated in the Dow Jones?
No, Elanco Animal Health Incorporated is not included in the Dow Jones index
When was Elanco Animal Health Incorporated the previous earnings report?
No data
When does Elanco Animal Health Incorporated earnings report?
The next expected earnings date for Elanco Animal Health Incorporated is 07 November 2024